2020
Chronic Disease Decision Making and “What Matters Most”
Fried TR, Street RL, Cohen AB. Chronic Disease Decision Making and “What Matters Most”. Journal Of The American Geriatrics Society 2020, 68: 474-477. PMID: 32043559, PMCID: PMC7197748, DOI: 10.1111/jgs.16371.Commentaries, Editorials and LettersConceptsOlder patientsChronic disease careClinical practice guidelinesPlan of careRobust outcome dataDifferent treatment optionsPatient-centered careMild cognitive impairmentAdverse eventsDisease careTreatment optionsChronic conditionsPractice guidelinesOutcome dataCognitive impairmentTreatment planPatientsCareMultimorbidityDisease decisionTherapyOutcomesOptionsSyndromeFrailty
2017
Guideline‐Recommended Medications and Physical Function in Older Adults with Multiple Chronic Conditions
McAvay G, Allore HG, Cohen AB, Gnjidic D, Murphy TE, Tinetti ME. Guideline‐Recommended Medications and Physical Function in Older Adults with Multiple Chronic Conditions. Journal Of The American Geriatrics Society 2017, 65: 2619-2626. PMID: 28905359, PMCID: PMC5729049, DOI: 10.1111/jgs.15065.Peer-Reviewed Original ResearchConceptsGuideline-recommended medicationsMultiple chronic conditionsCoronary artery diseasePhysical functionChronic conditionsHeart failureAtrial fibrillationSelf-reported declineOlder adultsArtery diseaseDiabetes mellitusRenin-angiotensin system blockersAngiotensin system blockersProspective observational cohortCommunity-dwelling adultsHealth risk factorsOverall sampleLess polypharmacyPolypharmacy exposureSystem blockersObservational cohortSingle medicationRisk factorsMedicationsLower risk
2016
Methodology to Estimate the Longitudinal Average Attributable Fraction of Guideline-recommended Medications for Death in Older Adults With Multiple Chronic Conditions
Allore HG, Zhan Y, Cohen AB, Tinetti ME, Trentalange M, McAvay G. Methodology to Estimate the Longitudinal Average Attributable Fraction of Guideline-recommended Medications for Death in Older Adults With Multiple Chronic Conditions. The Journals Of Gerontology Series A 2016, 71: 1113-1116. PMID: 26748093, PMCID: PMC4945884, DOI: 10.1093/gerona/glv223.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAgedAged, 80 and overCardiovascular DiseasesDrug PrescriptionsDrug Therapy, CombinationFemaleFollow-Up StudiesHumansMaleMedicareMultiple Chronic ConditionsPractice Guidelines as TopicRetrospective StudiesSurveys and QuestionnairesSurvival RateThiazidesTreatment OutcomeUnited StatesConceptsMultiple chronic conditionsAverage attributable fractionChronic conditionsAttributable fractionCardiovascular conditionsHeart failureMedicare Current Beneficiary Survey participantsRenin-angiotensin system blockersGuideline-recommended medicationsMore chronic conditionsAge-stratified modelsSystem blockersBeta blockersCardiovascular medicationsOral medicationsAtrial fibrillationMedication effectsMedicationsAge strataParticipant characteristicsOlder adultsSurvivalThiazidesBlockersAge
2015
Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study
Tinetti ME, McAvay G, Trentalange M, Cohen AB, Allore HG. Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. The BMJ 2015, 351: h4984. PMID: 26432468, PMCID: PMC4591503, DOI: 10.1136/bmj.h4984.Peer-Reviewed Original ResearchConceptsSerotonin-norepinephrine reuptake inhibitorsMultiple chronic conditionsSelective serotonin reuptake inhibitorsAdjusted hazard ratioRisk of deathCalcium channel blockersChronic conditionsHazard ratioΒ-blockersCohort studyReuptake inhibitorsAtrial fibrillationOlder adultsChannel blockersCardiovascular drugsSSRIs/serotonin-norepinephrine reuptake inhibitorsRenin-angiotensin system blockersNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitorsCommon combinationRAS blockersSystem blockersStudy drugHeart failureThromboembolic disease